See the DrugPatentWatch profile for nesina
What is “Nesina” and what patent is usually meant?
“Nesina” is the brand name used for linagliptin, a medicine in the DPP-4 inhibitor class. When people ask about “patente nesina,” they usually mean when the linagliptin patents or market exclusivity expire (so generics or biosimilars can enter), or which patents cover the drug in a specific country. The exact answer depends on the jurisdiction (e.g., EU vs. US vs. Turkey), because patent and exclusivity timelines differ by country.
How can you find the exact patent timeline for Nesina (linagliptin)?
To determine “patente nesina” in a reliable way, you need three inputs:
1) Country/region (patent registers and exclusivity rules differ).
2) Product form (often the same active ingredient but different formulations can be covered by different filings).
3) Which kind of exclusivity you mean:
- Basic patent expiry (the core patent on the drug/product)
- Supplementary protection certificates (SPC) or equivalent extensions (common in Europe)
- Regulatory data exclusivity / marketing protection (separate from patents)
- Orphan/other special exclusivities (only if applicable)
When do generics typically enter if patents for Nesina expire?
Generic entry usually becomes possible only when at least one of the following barriers clears:
- the relevant patent(s) covering linagliptin/its protected claims expire or are successfully challenged; and/or
- regulatory exclusivity periods end; and/or
- the generic gets approval under the local rules for bioequivalence and patent linkage (regulatory frameworks differ by country).
Because these protections can overlap, the “expiry date” users see online is often a mix of patent expiry and regulatory exclusivity.
Is Nesina’s patent situation the same everywhere?
No. A “Nesina patent” question can produce different dates depending on:
- whether you’re asking about the US (patent terms and regulatory exclusivity differ),
- the EU/EEA (SPC can extend protection beyond the basic patent term),
- or another country (different patent filing dates and term adjustments).
If you tell me the country, I can answer with the right dates
Which country are you asking about (for example: Türkiye, Avrupa Birliği, ABD, Birleşik Krallık)? Also, do you want the first patent expiry date or the final exclusivity/market-protection end date?